Discussing whether the company's restructuring efforts has paid off, and its ability to compete in the big pharma space, with George Scangos, Biogen CEO.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT